Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
Elizabeth Holmes’ Trial Judge Leaves Us Hanging
Medical Devices and Diagnostics Industry
Sunday, March 19, 2023 - 1:37pm
tags:
Elizabeth Holmes, legal, Theranos, fraud
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Endpoints
Sunday, March 19, 2023 - 1:36pm
tags:
Novartis, Tafinlar, Mekinist, pediatric, brain cancer, FDA
FDA agrees to give Ipsen's rare disease drug another look as palovarotene saga rumbles on
Fierce Biotech
Sunday, March 19, 2023 - 1:34pm
tags:
Ipsen, FDA, palovarotene, fibrodysplasia ossificans progressiva
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Saturday, March 18, 2023 - 3:37pm
tags:
Medtronic, Medtech, inflation, drug pricing, Pfizer, Novartis, Merck, Bristol Myers Squibb, Keytruda, Opdivo, Yervoy, lung cancer, Xiidra, JNJ, executive compensation
Alzheimer's Association campaigns for broader Leqembi coverage: report
Fierce Pharma
Friday, March 17, 2023 - 11:43am
tags:
CMS, Eisai, Biogen, Leqembi, Alzheimer's disease
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Fierce Biotech
Friday, March 17, 2023 - 11:41am
tags:
Acer Therapeutics, clinical trials, hot flashes, menopause, osanetant
Pfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packaging
USA Today
Friday, March 17, 2023 - 10:18am
tags:
Pfizer, Nurtec ODT, migraines, packaging, product recalls
FDA Reverses Course; Will Hold Adcomm for Sarepta’s DMD Gene Therapy
BioSpace
Friday, March 17, 2023 - 10:13am
tags:
FDA, Sarepta Therapeutics, DMD, gene therapy, Duchenne Muscular Dystrophy, SRP-9001
Daiichi torches Esperion’s Nexletol milestone promises
EP Vantage
Friday, March 17, 2023 - 10:10am
tags:
Daiichi Sankyo, Esperion Therapeutics, Nexletol
Moderna, riding COVID success and busy growing its pipeline, hikes pay of CEO Bancel to $19.4M
Fierce Pharma
Friday, March 17, 2023 - 10:07am
tags:
Moderna Therapeutics, Pharma CEOs, Stephane Bancel, executive compensation
Biogen's head of neurodegeneration leaves
Fierce Biotech
Friday, March 17, 2023 - 10:03am
tags:
Biogen, women executives, Aduhelm, Alzheimer's disease
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Friday, March 17, 2023 - 10:02am
tags:
Pfizer, Astellas, prostate cancer, clinical trials, Enzalutamide, leuprolide
Amgen cites inflation, pressure on drug prices in 450-person layoff
Endpoints
Friday, March 17, 2023 - 9:59am
tags:
Amgen, California, layoffs
BeiGene pulls out of Leap of faith, letting option on immuno-oncology candidate lapse
Fierce Biotech
Friday, March 17, 2023 - 9:55am
tags:
BeiGene, immuno-oncology, Leap Therapeutics, DKN-01
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thursday, March 16, 2023 - 9:16pm
tags:
Sanofi, Lantus, insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'
Fierce Biotech
Thursday, March 16, 2023 - 9:09pm
tags:
Organon, Women's Health, endometriosis
AstraZeneca employees fight layoffs in India as drugmaker shifts 'strategic priorities'
Fierce Pharma
Thursday, March 16, 2023 - 9:07pm
tags:
AstraZeneca, layoffs, India
Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class
Fierce Biotech
Thursday, March 16, 2023 - 7:02pm
tags:
Merck, Keytruda, clinical trials, vibostolimab, non-small cell lung cancer, metastatic non-small cell lung cancer
SEC says Eli Lilly can't avoid requests for more info on diversity efforts, abortion stance
Endpoints
Thursday, March 16, 2023 - 7:00pm
tags:
Eli Lilly, SEC, abortion, diversity, DEI, Indiana
CMS lays out plans for negotiating drug prices
BioPharma Dive
Thursday, March 16, 2023 - 6:57pm
tags:
CMS, Medicare, drug pricing

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)
Drug Channels
Winning the Race for Patient Access: Identifying Copay Accumulator Impact
Drug Channels
Gene Drives Are Coming
In the Pipeline
Organizing Our Thoughts About Cells - Finally
In the Pipeline
Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists
Drug Channels
The Right Assay With the Right Cells
In the Pipeline
Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress
Drug Channels
Peptide-Encoded Screening Libraries
In the Pipeline
It's Not All Bad News: Data Shows There's a Collaborative Future for 340B
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information